Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
CC transcript
Inv. presentation
Director comp.
Assertio Therapeutics, Inc (ASRT) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/11/2020 8-K Quarterly results
03/09/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
Docs: "Assertio Therapeutics Announces Third-Quarter 2019 Results -- Company Implements New Cost Savings Initiatives Expected to Deliver Annualized Savings of $20.0 Million -- -- Raises Full-Year 2019 Earnings Guidance Ranges -- -- Lowers Full-Year 2019 Neurology Franchise Net Sales Guidance -- -- Reduces Total Debt by $200.0 Million Year to Date -- -- Extends Significant Portion of Convertible Debt Maturity to 2024 --"
05/08/2019 8-K Quarterly results
Docs: "Assertio Therapeutics Announces First-Quarter 2019 Financial Results -- Reports Neurology Franchise Net Sales of $26.3 million -- -- Commercialization Agreement Revenues of $30.9 million -- -- Raises 2019 Earnings Guidance Range and Confirms Neurology Franchise Net Sales Guidance -- -- Significant Debt Reduction --"
03/06/2019 8-K Quarterly results
Docs: "Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2018 Financial Results -- Reports Neurology Franchise Annual Net Sales of $110.3 million, at the High End of Guidance Range -- -- Files NDA for Long-acting Cosyntropin and Receives FDA Notification of Acceptance -- -- Issues Full-Year 2019 Guidance for Earnings and Neurology Franchise Net Sales --"
11/08/2018 8-K Quarterly results
Docs: "Assertio Therapeutics Announces Third-Quarter 2018 Financial Results -- Confirms Full-Year Net Sales Guidance Range for the Neurology Franchise -- -- Raises Full-Year Earnings Guidance and Confirms Adjusted EBITDA Guidance -- -- Amends and Strengthens Commercial Agreement with Collegium -- -- Confirms Regulatory Plan to File for FDA Approval of Cosyntropin Depot by Year End --"
05/10/2018 8-K Quarterly results
Docs: "Depomed Announces First-Quarter 2018 Financial Results"
02/27/2018 8-K Quarterly results
Docs: "Depomed Announces Fourth Quarter and Full Year 2017 Financial Results"
11/07/2017 8-K Quarterly results
Docs: "Depomed Announces Third Quarter 2017 Financial Results"
08/07/2017 8-K Quarterly results
Docs: "Depomed Announces Second Quarter 2017 Financial Results - Updates Full-Year Financial Guidance - - Second Quarter Revenues of $100 million - - Increases Neurology Salesforce Effective September 1 - - Conference Call Scheduled for Today at 4:30 PM EDT; Dial In Information Below -"
05/09/2017 8-K Form 8-K - Current report
02/21/2017 8-K Form 8-K - Current report
11/07/2016 8-K Quarterly results
Docs: "Depomed Reports Third Quarter 2016 Financial Results - Third Quarter Revenues of $111 million - - Conference Call Scheduled for Today at 4:30 PM EST; Dial-In Information Below -"
08/03/2016 8-K Quarterly results
Docs: "Depomed Reports Second Quarter 2016 Financial Results - Second Quarter Revenues of $117 million, 23% over 2Q 2015 - - NUCYNTA® Franchise Second Quarter 2016 Record Net Sales of $72 million, 27% over 2Q 2015 - - Conference Call Scheduled for Today at 4:30 PM EDT; Dial In Information Below -"
08/07/2013 8-K Quarterly results
Docs: "Depomed Reports Second Quarter 2013 Financial Results"
05/08/2013 8-K Quarterly results
Docs: "Depomed Reports First Quarter 2013 Financial Results"
02/20/2013 8-K Quarterly results
Docs: "Depomed Reports Fourth Quarter and Full Year 2012 Financial Results"
11/05/2012 8-K Quarterly results
Docs: "Depomed Reports Third Quarter Financial Results"
08/02/2012 8-K Quarterly results
Docs: "Depomed Reports Second Quarter Financial Results"
05/08/2012 8-K Quarterly results
Docs: "Depomed Reports First Quarter Financial Results"
03/08/2012 8-K Quarterly results
Docs: "Depomed Reports Fourth Quarter and Year-End 2011 Financial Results"
11/01/2011 8-K Form 8-K - Current report
08/01/2011 8-K Quarterly results
Docs: "Depomed Reports Second Quarter 2011 Financial Results"
05/05/2011 8-K Form 8-K - Current report
11/01/2010 8-K Form 8-K - Current report
08/05/2010 8-K Quarterly results
Docs: "DEPOMED REPORTS SECOND QUARTER 2010 FINANCIAL RESULTS"
04/29/2010 8-K Quarterly results
Docs: "DEPOMED REPORTS FIRST QUARTER 2010 FINANCIAL RESULTS"
03/04/2010 8-K Form 8-K - Current report
10/29/2009 8-K Quarterly results
Docs: "DEPOMED REPORTS THIRD QUARTER 2009 FINANCIAL RESULTS"
07/30/2009 8-K Quarterly results
Docs: "DEPOMED REPORTS SECOND QUARTER 2009 FINANCIAL RESULTS"
05/04/2009 8-K Form 8-K -- Current report
03/05/2009 8-K Quarterly results
Docs: "DEPOMED REPORTS FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS"
10/30/2008 8-K Quarterly results
Docs: "DEPOMED REPORTS THIRD QUARTER 2008 FINANCIAL RESULTS"
07/31/2008 8-K Quarterly results
Docs: "DEPOMED REPORTS SECOND QUARTER 2008 FINANCIAL RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy